Clinical Trial Update: Clinical Study of Geranium Wilfordii Combined With Androgen Deprivation in Neoadjuvant Therapy of Prostate Cancer [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial is evaluating Geranium Wilfordii combined with androgen deprivation as neoadjuvant therapy for prostate cancer, which is not yet recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Androgen deprivation therapy (Androgen deprivation therapy)
• Geranium Wilfordii (Geranium wilfordii)

Snippet

Sponsor: baotai Liang | Conditions: Prostate CA | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING